Delivery Order SPE2DB20D9127-SPE2DB25FPQE4

Award Date 4/1/25
Potential Completion Date 4/2/25
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $8,444.16 firm fixed-price delivery order is for the provision of 4567653313 - Omeprazole DR 10 mg Capsule 30s, a prescription medication. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,066.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of omeprazole extended-release medication to support the recurring medical supply needs of military healthcare facilities. This delivery order is part of a larger single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,248.00, is for the delivery of 4,567,792,099 units of the drug Omeprazole DR 10 mg capsules. The contract has an ultimate completion date of March 28, 2025. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA...
This federal contract award is for the delivery of OMEPRAZOLE DR 10 MG CAPSULE 100S to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 21, 2023, with a ceiling value of $1,170.40 and a completion date of June 22, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc.,...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $2,111.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of omeprazole delayed-release 10 mg capsules to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This federal contract award, valued at $1,116.22, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for the supply of 4,567,221,354 units of Omeprazole DR 40 mg Capsules in 500-count packaging. The contract is a Firm Fixed Price agreement with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has an Indefinite...
This is a federal contract award by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,098.93, is for the delivery of OMEPRAZOLE DR 20 MG CAPSULE 1000S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $1,002.80, is for the delivery of Omeprazole extended-release medication to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription drugs,...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $6,609.34, is a firm fixed-price delivery order to provide the DLA with Prilosec DR 2.5 mg suspension for a period ending on December 4, 2024. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,739.59 firm fixed-price delivery order is for 500 capsules of 40 mg Omeprazole Delayed-Release medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive...
  • SPE2DB20D9127
    Indefinite Delivery Contract
  • SPE2DB20D9127-SPE2DB25FPQE4
    Delivery Order

The federal contract award SPE2DB20D9127/SPE2DB25FPQE4 was issued by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business. The $2,521.36 firm fixed-price delivery order contract is for the provision of 4567764104 - OMEPRAZOLE DR 10 MG CAPSULE 30S, a pharmaceutical product. This award is associated with a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation.

Generated 7/1/25, 10:20 AM